Defining potency: A comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite

Authors

  • Florian R. Schroeck MD,

    1. Duke Prostate Center, Division of Urology, Department of Surgery, Duke University Medical Center, Durham, North Carolina
    Search for more papers by this author
  • Craig F. Donatucci MD,

    1. Duke Prostate Center, Division of Urology, Department of Surgery, Duke University Medical Center, Durham, North Carolina
    Search for more papers by this author
  • Emily C. Smathers MPH,

    1. Duke Prostate Center, Division of Urology, Department of Surgery, Duke University Medical Center, Durham, North Carolina
    Search for more papers by this author
  • Leon Sun MD, PhD,

    1. Duke Prostate Center, Division of Urology, Department of Surgery, Duke University Medical Center, Durham, North Carolina
    Search for more papers by this author
  • David M. Albala MD,

    1. Duke Prostate Center, Division of Urology, Department of Surgery, Duke University Medical Center, Durham, North Carolina
    Search for more papers by this author
  • Thomas J. Polascik MD,

    1. Duke Prostate Center, Division of Urology, Department of Surgery, Duke University Medical Center, Durham, North Carolina
    Search for more papers by this author
  • Judd W. Moul MD,

    1. Duke Prostate Center, Division of Urology, Department of Surgery, Duke University Medical Center, Durham, North Carolina
    Search for more papers by this author
  • Tracey L. Krupski MD, MPH

    Corresponding author
    1. Duke Prostate Center, Division of Urology, Department of Surgery, Duke University Medical Center, Durham, North Carolina
    • Division of Urology, Department of Surgery, Duke University Medical Center, 3480 Wake Forest Road, Suite 506, Raleigh, NC 27609===

    Search for more papers by this author
    • Fax: (919) 862-5605.


Abstract

BACKGROUND.

Both the 5-item short version of the International Index of Erectile Function (IIEF-5) and the Expanded Prostate Cancer Index Composite (EPIC) have been used to assess erectile function. In this study, the authors compared various definitions of potency according to the IIEF-5 and the EPIC.

METHODS.

Patients with prostate cancer who had completed the IIEF-5 and the EPIC within 7 days of each other were included. The Spearman correlation coefficient (rho) was calculated to assess the relation between IIEF-5 and EPIC sexual domain scores. Concordance of potency rates by IIEF-5 and EPIC was assessed in cross-tabulations. By calculating the area under the receiver operator characteristics (ROC) curve (AUC), the authors ascertained the discriminative ability of the IIEF-5 score to identify potent men as defined by the EPIC.

RESULTS.

Analyzing 102 questionnaire pairs, IIEF-5 and EPIC domain scores were found to be highly correlated (rho = 0.776). EPIC sexual domain scores ≥60 had high concordance with IIEF-5 scores ≥17 (98%) and with nearly all single-item definitions of potency (≥71%). However, an EPIC sexual domain score ≥80 was a very strict definition of potency, and only 54% of patients with IIEF-5 scores ≥22 met this threshold. On the basis of ROC analysis (AUC = 0.90), an IIEF-5 score ≥20 was identified as the ideal cutoff for defining potency and corresponded with an EPIC sexual domain score ≥60.

CONCLUSIONS.

IIEF-5 and EPIC scores were highly correlated, but potency rates varied widely, depending on the definition of potency. The current results help with the interpretation of sexual function outcomes data in patients with prostate cancer. Cancer 2008. © 2008 American Cancer Society.

Ancillary